Compound ID |
Cluster
|
Compound Type
|
Target Name | Img | Activity | Assay Description | Source | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Type
|
Relation
|
Value
|
Unit
|
||||||||
NAs.000083 | 7 | ribose-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
Ki | < | 6309.57 | nM | PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1 | CHEMBL1201862 | |
NAs.000389 | 7 | ribose-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
Kd | > | 30000.0 | nM | Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry. | CHEMBL3991601 | |
NAs.001065 | 7 | all-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
Ki | = | 15848.93 | nM | PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1 | CHEMBL1201862 | |
NAs.002742 | 7 | ribose-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
Inhibition | = | 1.05 | % | GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn] | CHEMBL1961873 | |
NAs.002742 | 7 | ribose-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
Inhibition | = | 3.79 | % | GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn] | CHEMBL1961873 | |
NAs.002770 | 7 | ribose-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
Kd | None | None | None | Average Binding Constant for PRKAA1; NA=Not Active at 10 uM | CHEMBL1144455 | |
NAs.002770 | 7 | ribose-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
Kd | > | 10000.0 | nM | Binding constant for AMPK-alpha1 kinase domain | CHEMBL1150977 | |
NAs.002770 | 7 | ribose-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
Kd | > | 30000.0 | nM | Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry. | CHEMBL3991601 | |
NAs.003215 | 2 | all-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
Ki | < | 1584.89 | nM | PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1 | CHEMBL1201862 | |
NAs.003270 | 7 | all-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
Ki | = | 125.89 | nM | PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1 | CHEMBL1201862 | |
NAs.003271 | 7 | base-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
Kd | > | 30000.0 | nM | Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry. | CHEMBL3991601 | |
NAs.003485 | 2 | ribose-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
Kd | > | 30000.0 | nM | Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry. | CHEMBL3991601 | |
NAs.004092 | 7 | all-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
Ki | = | 50118.72 | nM | PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1 | CHEMBL1201862 | |
NAs.005346 | 7 | base-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
IC50 | > | 10000.0 | nM | Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 μl/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction. | CHEMBL3886794 | |
NAs.008133 | 7 | ribose-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
Kd | > | 30000.0 | nM | Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry. | CHEMBL3991601 | |
NAs.008387 | 7 | ribose-match | AMP-activated protein kinase, alpha-1 subunit | ![]() |
Activity | = | 119.5 | % | Inhibition of recombinant full-length human AMPKalpha1 assessed as residual activity at 10 uM using AMARAASAAALARRR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method | CHEMBL4311992 |